Mereo BioPharma Group PLC ADR (MREO) support and resistance · $48.7M cap
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
This page maps Mereo BioPharma Group PLC ADR (MREO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
MREO currently screens at market cap $48.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MREO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MREO quote page for the session range and the stock page for the full model.
Not investment advice.